245
Participants
Start Date
October 31, 2006
Primary Completion Date
August 31, 2010
Study Completion Date
July 31, 2011
Arctic Front® Cryoablation Catheter
Experimental Subjects received cryoablation intended to isolate the pulmonary veins and ablate arrhythmia foci with the cryoablation catheter system.
Flecainide or Sotalol or Propafenone
Flecainide 200 mg / day Propafenone 450 mg / day Propafenone-SR 650 mg / day Sotalol 240 mg / day
Montefiore Medical Center, The Bronx
Inova Research Center, Falls Church
Medical College of Virginia, Richmond
Sentara CV Research Institute, Norfolk
Emery Crawford Long Hospital, Atlanta
Piedmont Hospital, Atlanta
Mayo Clinic- Jacksonville, Jacksonville
BayHeart Group -- St-Joseph's Hospital, Tampa
Cleveland Clinic Foundation, Cleveland
Iowa Heart Center, Des Moines
Arrhythmia Center of Southern WI, Milwaukee
Mayo Clinic, Rochester
Baylor Heart and Vascular Hospital, Dallas
Colorado Cardiac Alliance -- Memorial Hospital, Colorado Springs
Banner Good Samaritan Medical Center, Phoenix
New Mexico Heart Institute, Albuquerque
Cedar Sinai Medical Center, Los Angeles
UC Davis Medical Center, Sacramento
University of Alabama, Birmingham
Stanford Hospital, Stanford
Massachusetts General Hospital, Boston
University of Pennsylvania Health, Philadelphia
Cardiology Associates of Green Bay, Green Bay
London Medical Health Sciences, London
Montreal Heart Institute, Montreal
Laval Hospital, Ste-Foy
Collaborators (1)
Medtronic
INDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY